Patients who experience recurrence of COVID-19 symptoms after completing treatment with Pfizer drug Paxlovid should be isolated again for five days, according to a suggestion issued Tuesday by the US Center for Disease Control and Prevention.
Dozens of people have reported recovery of Covid’s symptoms on social media or the U.S. Food and Drug Administration after taking Paxlovid, but Pfizer suggested the experience is rare. The recent rise in the Cowid case has driven therapeutic use in the country.
The CDC said in its advice https://bit.ly/3sSexC0 that case reports indicate that recurrence causes mild symptoms and no serious illness has been reported so far. Despite the possibility of recurrence, the company continues to recommend oral antiviral drugs as a treatment.
Regardless of treatment with Paxlovid, a brief relapse of symptoms may be part of the natural history of SARS-CoV-2 infection in some individuals, the agency said.
The CDC recommends that patients with covid rebound may have their recurrence period five days later if they do not have a 24-hour fever and symptoms do not improve, but such patients should wear a mask for a total of 10 days after the onset of rebound symptoms.
(Reporting by Manas Mishra in Bangalore; Edited by Shailesh Kuber)